Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IMPDH2 | P12268 | 7/20 | 0.66 |
| ▸ | IMPDH1 | P20839 | 2/20 | 0.66 |
| ▸ | TAS1R3 | Q7RTX0 | 3/20 | 0.62 |
| ▸ | TAS1R1 | Q7RTX1 | 3/20 | 0.62 |
| ▸ | DNPH1 | O43598 | 3/20 | 0.58 |
| ▸ | FBP1 | P09467 | 2/20 | 0.58 |
| ▸ | PRKAB2 | O43741 | 1/20 | 0.58 |
| ▸ | TRPM2 | O94759 | 1/20 | 0.58 |
| ▸ | LDHA | P00338 | 1/20 | 0.58 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.58 |
| ▸ | SRC | P12931 | 1/20 | 0.58 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.58 |
| ▸ | P2RY2 | P41231 | 1/20 | 0.58 |
| ▸ | P2RY1 | P47900 | 1/20 | 0.58 |
| ▸ | PRKAG1 | P54619 | 1/20 | 0.58 |
| ▸ | PRKAA2 | P54646 | 1/20 | 0.58 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.58 |
| ▸ | KCNH2 | Q12809 | 1/20 | 0.58 |
| ▸ | PRKAA1 | Q13131 | 1/20 | 0.58 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.58 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12727828 | 1.00 | IMPDH2 (0.66) | IMPDH2IMPDH1TAS1R3TAS1R1DNPH1 | |
| SCHEMBL22986473 | 1.00 | IMPDH2 (0.66) | IMPDH2IMPDH1TAS1R3TAS1R1DNPH1 | |
| SCHEMBL27862445 | 1.00 | IMPDH2 (0.66) | IMPDH2IMPDH1TAS1R3TAS1R1DNPH1 | |
| SCHEMBL4356337 | 1.00 | IMPDH2 (0.66) | IMPDH2IMPDH1TAS1R3TAS1R1DNPH1 | |
| SCHEMBL2217345 | 1.00 | IMPDH2 (0.66) | IMPDH2IMPDH1TAS1R3TAS1R1DNPH1 | |
| SCHEMBL188739 | 1.00 | IMPDH2 (0.66) | IMPDH2IMPDH1TAS1R3TAS1R1DNPH1 | |
| SCHEMBL20266268 | 0.99 | IMPDH2 (0.65) | IMPDH2IMPDH1TAS1R3TAS1R1DNPH1 | |
| SCHEMBL22635931 | 0.99 | IMPDH2 (0.65) | IMPDH2IMPDH1TAS1R3TAS1R1DNPH1 | |
| Phosphoric Acid SCHEMBL30728570 | 0.99 | IMPDH2 (0.65) | IMPDH2IMPDH1TAS1R3TAS1R1DNPH1 | |
| SCHEMBL28340155 | 0.99 | IMPDH2 (0.65) | IMPDH2IMPDH1TAS1R3TAS1R1DNPH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4223352-B1 | DRUG-COATED BALLOON CATHETERS FOR BODY LUMENS | UROTRONIC INC (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | MARS, INCORPORATED (US) | 2026-04-30 | — | — | US | claimed |
| US-12605342-B2 | Polymer-encapsulated drug particles | TONIC MEDICAL, INC. (US) | 2026-04-21 | — | — | US | claimed |
| EP-4593631-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | Mars, Incorporated (US) | 2025-08-06 | — | — | EP | claimed |
| US-12280226-B2 | Drug-coated balloon catheters for body lumens | UROTRONIC, INC. (US) | 2025-04-22 | — | — | US | claimed |
| CN-119733157-A | Drug coated balloon catheter for non-vascular stenosis | 江苏长寿棒科技有限公司 | 2025-04-01 | — | — | CN | claimed |
| US-20250082582-A1 | POLYMER-ENCAPSULATED DRUG PARTICLES | TONIC MEDICAL, INC. | 2025-03-13 | — | — | US | claimed |
| US-20250025673-A1 | METHOD FOR TREATMENT OF AIRWAY STRICTURE OR STENOSIS | AIRIVER MEDICAL, INC. | 2025-01-23 | — | — | US | claimed |
| CN-119303213-A | Drug-coated balloon catheter for body cavities | 优敦力公司 | 2025-01-14 | — | — | CN | claimed |
| US-20240416013-A1 | DRUG-COATED BALLOON CATHETERS FOR BODY LUMENS | UROTRONIC, INC. | 2024-12-19 | — | — | US | claimed |
| EP-1901622-A1 | TASTE POTENTIATOR COMPOSITIONS AND BEVERAGES CONTAINING SAME | Cadbury Adams USA LLC (US) | 2008-03-26 | — | — | EP | claimed |
| CN-101132804-A | Fetal skin cell protein compositions for the treatment of skin conditions, disorders or diseases and methods of making and using the same | NEOCUTIS SA (CH) | 2008-02-27 | — | — | CN | claimed |
| CN-100347562-C | Magnetic resonance research method | AIMOSJAM HEALTH AS (NO) | 2007-11-07 | — | — | CN | claimed |
| US-20060286203-A1 | Taste potentiator compositions and edible confectionery and chewing gum products containing same | CADBURY ADAMS USA LLC | 2006-12-21 | — | — | US | claimed |
| US-20060286259-A1 | Taste potentiator compositions and beverages containing same | CADBURY ADAMS USA LLC | 2006-12-21 | — | — | US | claimed |
| US-20060286202-A1 | Taste potentiator compositions and edible confectionery and chewing gum products containing same | CADBURY ADAMS USA LLC | 2006-12-21 | — | — | US | claimed |
| WO-2006127934-A2 | TASTE POTENTIATOR COMPOSITIONS AND EDIBLE CONFECTIONERY AND CHEWING GUM PRODUCTS CONTAINING SAME | CADBURY ADAMS USA, LLC (US) | 2006-11-30 | — | — | WO | claimed |
| WO-2006127936-A2 | TASTE POTENTIATOR COMPOSITIONS AND EDIBLE CONFECTIONERY AND CHEWING GUM PRODUCTS CONTAINING SAME | CADBURY ADAMS USA LLC (US) | 2006-11-30 | — | — | WO | claimed |
| WO-2006127935-A1 | TASTE POTENTIATOR COMPOSITIONS AND BEVERAGES CONTAINING SAME | CADBURY ADAMS USA LLC (US) | 2006-11-30 | — | — | WO | claimed |
| US-5891452-A | Cosmetic or dermatological composition containing at least one active principle precursor and a crosslinked poly(2-acrylamido-2-methylpropanesulphonic acid) polymer neutralized to at least 90% | L'OREAL (FR) | 1999-04-06 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12605342-B2 | Polymer-encapsulated drug particles | MUC1, SLC10A2, EGFR | IMPDH2 4390/4885IMPDH1 4568/4885TAS1R3 374/4885 |
| US-20250082582-A1 | POLYMER-ENCAPSULATED DRUG PARTICLES | CD47, GRPR, HSPA5 | IMPDH2 4701/4885IMPDH1 4748/4885TAS1R3 1262/4885 |
| US-20260114475-A1 | ANIMAL FOOD COMPOSITIONS WITH IMPROVED PALATABILITY AND CUSTOMIZABILITY, AND METHODS FOR PREPARING THE SAME | PIGS, TAS2R13, CEL | IMPDH2 3474/4885IMPDH1 4172/4885TAS1R3 44/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.